5-((((1R,2S)-2-(4-(Benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine

Catalog No. :
ACXRRQ291
CAS No. :
1357362-02-7
Molecular Formula :
C19H20N4O2
Molecular Weight :
336.39

IUPAC Name:Vafidemstat

5-((((1R,2S)-2-(4-(Benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg99%$133.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((((1R,2S)-2-(4-(Benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine
IUPAC NameVafidemstat
MDL No.MFCD31692412
Molecular FormulaC19H20N4O2
Molecular Weight336.39
SMILESNC1=NN=C(O1)CN[C@@H]2C[C@H]2C3=CC=C(OCC4=CC=CC=C4)C=C3
InChI KeyXBBRLCXCBCZIOI-DLBZAZTESA-N
Synonym(1R,2S)-2-(4-(Benzyloxy)phenyl)-N-((5-imino-4,5-dihydro-1,3,4-oxadiazol-2-yl)methyl)cyclopropanamine | MS-25100 | BCP29383 | ORY 2001; ORY-2001; ORY2001 | AKOS040742807 | UNII-LZ82JLT4UP | 1357362-02-7 | 1,3,4-Oxadiazole-2-methanamine, 4,5-dihydro-5-imino
CAS No.1357362-02-7
PubChem CID66714983

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACXRRQ291 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXRRQ291 route product structure diagram
    ACXRRQ2911357362-02-7
Inquiry

2. ACXRRQ291 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  6. Then
  7. ACXRRQ291 route product structure diagram
    ACXRRQ2911357362-02-7
Inquiry

Comments (0)